Brenus Pharma — Sponsor Intelligence | 1 EU Trials

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

2 Countries active

6 Unique IMPs

N/A Results reported

Phase I (FiH)

Top IMPs

1 total

BreAK CRC (001) trial Recruiting

2024-512011-45-00 Phase I (FiH) 2 countries ANHYDROUS CYCLOPHOSPHAMIDE; HCT116-A, HCT116-B, HT-29-A, HT-29-B, LOVO-B, LOVO-A…

Showing 1–1 of 1 trials